CSPC PHARMA (01093) grants a total of 78.085 million restricted shares.
CSPC PHARMA (01093) announces that on October 16, 2026, the Company granted a total of 78.085 million restricted shares to 205 selected participants of the Group under the 2026 Share Award Scheme, subject to acceptance by the grantees and the fulfillment of certain vesting conditions and performance targets.
CSPC PHARMA (01093) announced that on October 16, 2026, the Company granted a total of 78.085 million restricted shares to 205 selected participants of the Group under the 2026 Share Award Scheme, subject to acceptance by the grantees and the fulfillment of certain vesting conditions and performance targets.
Related Articles
RONSHINECHINA (03301) total contracted sales for the first 9 months were approximately RMB 1.88 billion, a year-on-year decrease of 37.33%.
YUM CHINA (09987) repurchased 23,200 shares for approximately HK$7.9938 million on October 15.
FE HORIZON (03360) Third Quarter Operating Revenue and Profit Attributable to Ordinary Shareholders Increased Slightly Year-on-Year
RONSHINECHINA (03301) total contracted sales for the first 9 months were approximately RMB 1.88 billion, a year-on-year decrease of 37.33%.
YUM CHINA (09987) repurchased 23,200 shares for approximately HK$7.9938 million on October 15.
FE HORIZON (03360) Third Quarter Operating Revenue and Profit Attributable to Ordinary Shareholders Increased Slightly Year-on-Year
